Latest "Maroon Biotech,Corp." News Stories

22:09 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Maroon Biotech,Corp." found in our extensive news archives from over 250 global news sources.

More Information about Maroon Biotech,Corp. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Maroon Biotech,Corp. for you to read. Along with our medical data and news we also list Maroon Biotech,Corp. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Maroon Biotech,Corp. Companies for you to search.

Showing "Maroon Biotech Corp" News Articles 1–25 of 6,300+

Tuesday 18th December 2018

TLRY Teams Up With Novartis, TLSA To Report Data In Q2, RARX Marches Ahead

The following are some of today's top gainers in the pharma/biotech sector.

Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis

Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma’s First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals). AKP-11 is a differentiated S1P1 modulator, which potentially has clinical applications in a number ...

Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) introduces its financial outlook for 2019. Ligand expects revenue in 2019 to be at least $212 million, with up to an additional $40 million of potential milestone and license payments. Approximately two thirds of the $212 million of revenue is expected to be royalty revenue, and the remainder is expected t...

Man, even Sanofi is moving to Nasdaq. Turn out the lights on biotech listings at the NYSE.

Man, even Sanofi is moving to Nasdaq. Turn out the lights on biotech listings at the NYSE.


US FDA clears Bridge Biotherapeutics' IND application for BBT─877 to treat IPF

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS TMC in Houston, Texas, announced that the Investigational New

BB Biotech-Aktie: Charttechnische Analyse!

Der Seitwärtstrend hat seine Unterstützungslinien verloren. Die gleitenden Durchschnitte sind wieder in eine Widerstandsposition übergegangen. Momentan befindet sich der Kurs der BB Biotech-Aktie i...

Crossix Customer Insights Team Named One of the Most Innovative Divisions of 2018 by PM360

The Crossix Customer Insights team has been named one of the Most Innovative Divisions of 2018 by PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device and diagnostics industries. Driven by client demand, the newly launched Customer Insights changes the way marketers use data analytics to create patien...

NGM Bio’s Jeff Jonker Joins Ambys Medicines as President & CEO

Jeff Jonker has been appointed president and CEO of Ambys Medicines. Jonker comes to the Redwood City, CA-based biotech from NGM Bio, where he was president. His experience also includes senior positions at Theravance Biopharma (NASDAQ: TBPH), Theravance (NASDAQ: THRX), Satori Pharmaceuticals, and Genentech. Ambys is developing treatments for liver diseases. In August, Ambys launched […]

PCI Biotech Holding ASA: PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company

Oslo (Norway), 18 December 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclo...

Know Labs CEO Phil Bosua Presents Overview of the Company’s Technology and Product Strategy

Know Labs, Inc. (OTCQB: KNWN) – a provider of diagnostic solutions, released today a video presentation highlighting the Know Labs non-invasive Bio-RFID™ technology and the product pathway for the company’s UBAND™ wearable. In the video presentation Company CEO Phil Bosua discusses the Company’s breakthrough technology, details the product strate...

With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca

A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche, Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. Erasca on Tuesday closed a $42 million Series A round led […]

Entrada Therapeutics Nabs $59M for Drugs that Gain “Entry” to Cells

When it comes to getting a drug into a cell, size matters. Small molecules can easily pass through the cellular membrane in a way that larger therapeutic proteins can’t, which makes it difficult to develop a biological drug that can reach its target, says Dipal Doshi, CEO of biotech startup Entrada Therapeutics. Entrada, which translates […]

ProMIS Neurosciences Inc.: ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek

ProMIS to showcase its Alzheimer's, Parkinson's and ALS programs at notable biotech investor eventsTORONTO and CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: P...

BB Biotech, Celgene und Co: Massives Verkaufssignal im Nasdaq Biotech Index

Die allgemeine Marktschwäche bekommt auch der Biotech-Sektor zu spüren. Im gestrigen Handel ist der Nasdaq Biotechnology Index auf ein neues 52-Wochen-Tief bei 3.125 Punkten abgestürzt. In den Schl...

Our IMED Biotech Unit EVP @MenePangalos delivered the opening lecture at @BritPharmSoc #Pharmacology2018, discussing hot trends in #pharmacology and how our 5Rs approach to #drugdiscovery has transformed our pipeline. Find out more here

Our IMED Biotech Unit EVP @MenePangalos delivered the opening lecture at @BritPharmSoc #Pharmacology2018, discussing hot trends in #pharmacology and how our 5Rs approach to #drugdiscovery has transformed our pipeline. Find out more here

VIDEO: Synairgen Developing COPD Treatment To Hold Off Further Viral Damage

UK-based biotech Synairgen spoke to Scrip about the development of its COPD therapy, which is for patients whose lung disease...   

USDM Life Sciences Launches Redesigned Website

Featuring Educational Resources for the Life Sciences Community SANTA BARBARA, Calif. (PRWEB) December 18, 2018 USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for the life sciences industry, unveiled a completely redesigned website at The site offers improved accessibility to educational content while creating ...

Folia Biotech Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryFolia Biotech Inc Folia Biotech is a biopharmaceutical company that research and develops vaccines against infectious diseases. The company uses its immunotherapeutic platform to discover and develop new treatments for cancer and immune diseases. Its immunotherapeutic platform comprises a novel tolllike receptor agonist nanoparticle. Folia Biotech develops novel vaccines based on its immuno...

PrimeGen Biotech LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryPrimeGen Biotech LLC PrimeGen is a biotechnology company offers research and therapeutic applications of adult stem cells. The company concentrates on the therapeutic potential of adipose stem cells, germline stem cells, blood based stem cells and reprogrammed stem cells. PrimeGen s technologies include adipose derived stem cells, germline stem cells, iPS cells and BM/Mesenchymal stem cells...

15 For ’19: Key Clinical Data to Watch For Next Year (Part 2)

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in the coming year. Today we’re circling back with the rest of the list, which includes studies of drugs for nonalcoholic steatohepatitis, cystic fibrosis, spinal muscular atrophy and more. Read on for the details. [Editor’s […]

Acticor Biotech Appoints Dr Andrea Comenducci as Medical Director

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombo-embolic diseases, including stroke and pulmonary embolism, today announced the appointment of Dr Andrea Comenducci MD as Medical Director in charge of clinical R&D and medical affairs. Dr Comenducci specialises in the cardiovascular field, and his priority ...

BB Biotech nimmt Kurs auf 53,90 Euro

Nach den Verlusten des Vortages ist der Abwärtstrend in dem Titel wieder klar intakt. Das Papier ging am nahezu am Tagestief aus dem Handel. Die lange rote Vortageskerze deutet auf weiter fallende ...

Monday 17th December 2018

VWR Traceable Three Channel Alarm Timer LCD Display; 62344-600

C $10.70 (0 Bids)End Date: Sunday Dec-23-2018 14:25:26 ESTBid now | Add to watch list Biotech365 : VWR Traceable Three Channel Alarm Timer LCD Display; 62344-600 BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

DOVA Plunges On Tepid Sales Outlook, ADIL Cooling Off, ACHN On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

Quick Search


News Quicklinks